TITAN PHARMACEUTICALS INC — Director's Dealing 2015

Aug 26, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP.OB)
CIK: 0000910267
Period of Report: 2015-08-25

Reporting Person: BHONSLE SUNIL (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-25	Common Stock	P	50000	$0.696	Acquired	481500	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	300757	Indirect

Footnotes

F1: Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.6799 to $0.70. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F2: The reporting person serves as trustee of the family trust.